Skip to main content
Premium Trial:

Request an Annual Quote

People: Robert Saltmarsh, Nick Venuto

Premium
Robert Saltmarsh, the current vice president and chief financial officer at Nanogen, will retire from his position at the end of February 2008, the firm said last week. Saltmarsh will continue to consult with Nanogen through the end of next year as needed.
 
Nick Venuto, currently the firm's executive director of finance, has been named as Saltmarsh's successor. Venuto has been responsible for financial operations and reporting for the last four years.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.